Christopher R. Fenimore - Oct 3, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: SVP Controller
Signature: /s/**Christopher R. Fenimore
Stock symbol: REGN
Transactions as of: Oct 3, 2022
Transactions value $: -$2,422,504
Form type: 4
Date filed: 10/5/2022, 04:10 PM
Previous filing: Apr 11, 2022
Next filing: Oct 7, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Sale	-$2.42M	-3.35K	-15.48%	$724.00	18.3K	Oct 3, 2022	Direct	F1
holding	REGN	Common Stock						1.78K	Oct 3, 2022	2021 GRAT
holding	REGN	Common Stock						5K	Oct 3, 2022	2022 GRAT
holding	REGN	Common Stock						1.48K	Oct 3, 2022	By 401(k) Plan
holding	REGN	Common Stock						1.9K	Oct 3, 2022	By Trust	F2
holding	REGN	Common Stock						1.35K	Oct 3, 2022	by 2018 GRAT
holding	REGN	Common Stock						25	Oct 3, 2022	by Trust for Daugh
holding	REGN	Common Stock						25	Oct 3, 2022	by Trust for Son

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2	These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.